Expression profiles of mitochondrial genes in the frontal cortex and the caudate nucleus of developing humans and mice selectively bred for high and low fear by Choi, Kwang et al.
Expression Profiles of Mitochondrial Genes in the Frontal
Cortex and the Caudate Nucleus of Developing Humans
and Mice Selectively Bred for High and Low Fear
Kwang H. Choi1*, Thien Le1, Jennifer McGuire1, Jennifer Coyner1, Brandon W. Higgs2, Suad Diglisic3,
Luke R. Johnson1, David M. Benedek1, Robert J. Ursano1
1Department of Psychiatry, Center for the Study of Traumatic Stress, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States of America,
2 Elashoff Consulting, Redwood City, California, United States of America, 3 Stanley Medical Research Institute, Rockville, Maryland, United States of America
Abstract
A growing body of evidence suggests that mitochondrial function may be important in brain development and psychiatric
disorders. However, detailed expression profiles of those genes in human brain development and fear-related behavior
remain unclear. Using microarray data available from the public domain and the Gene Ontology analysis, we identified the
genes and the functional categories associated with chronological age in the prefrontal cortex (PFC) and the caudate
nucleus (CN) of psychiatrically normal humans ranging in age from birth to 50 years. Among those, we found that a
substantial number of genes in the PFC (115) and the CN (117) are associated with the GO term: mitochondrion (FDR qv
,0.05). A greater number of the genes in the PFC (91%) than the genes in the CN (62%) showed a linear increase in
expression during postnatal development. Using quantitative PCR, we validated the developmental expression pattern of
four genes including monoamine oxidase B (MAOB), NADH dehydrogenase flavoprotein (NDUFV1), mitochondrial
uncoupling protein 5 (SLC25A14) and tubulin beta-3 chain (TUBB3). In mice, overall developmental expression pattern of
MAOB, SLC25A14 and TUBB3 in the PFC were comparable to the pattern observed in humans (p,0.05). However, mice
selectively bred for high fear did not exhibit normal developmental changes of MAOB and TUBB3. These findings suggest
that the genes associated with mitochondrial function in the PFC play a significant role in brain development and fear-
related behavior.
Citation: Choi KH, Le T, McGuire J, Coyner J, Higgs BW, et al. (2012) Expression Profiles of Mitochondrial Genes in the Frontal Cortex and the Caudate Nucleus of
Developing Humans and Mice Selectively Bred for High and Low Fear. PLoS ONE 7(11): e49183. doi:10.1371/journal.pone.0049183
Editor: Monica Uddin, Wayne State University, United States of America
Received April 15, 2012; Accepted October 4, 2012; Published November 13, 2012
This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for
any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.
Funding: This study was partially supported by The Center for the Study of Traumatic Stress and the Stanley Medical Research Institute. The funders had no role
in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: Dr. BH, from Elashoff Consulting, provided microarray data analysis consulting service at the initial stage of the study. There are no
patents, products in development or marketed products to declare. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and
materials, as detailed online in the guide for authors.
* E-mail: kwang.choi@usuhs.edu
Introduction
A substantial number of genes in the brain undergo develop-
mental changes in psychiatrically normal subjects [1,2,3]. Many
genes implicated in psychiatric disorders exhibit dynamic expres-
sion changes during the first decade of life [1]. Thus, it is likely that
disruption of normal expression pattern of the susceptibility genes
during development may contribute to the development of
psychiatric symptoms in adulthood. Animal studies have shown
that adolescence is a sensitive period for the development of stress
and anxiety responses in adulthood [4,5]. For example, repeated
exposure of rats to a stressor across an adolescent period increase
fearfulness in a novel environment in adulthood and resulted in
lower levels of dopamine receptor subtype-2 levels in the
prefrontal cortex (PFC) [6]. One of the potential mechanisms
may include different hypothalamus-pituitary-adrenal (HPA) axis
responses to stressors in young and adult animals [7,8]. A slow
maturation of the PFC toward adulthood may contribute to
different stress responses in animals [9]. These studies implicate a
functional relationship between brain development, stress and
altered fear behavior.
The PFC is considered as one of the most functionally advanced
regions of the human cortex [10], mediating working memory,
response inhibition and management of autonomic control
[11,12]. The PFC has been implicated in the pathophysiology of
psychiatric disorders including schizophrenia, mood and anxiety
disorders [13,14,15,16]. Thus, disruption of the PFC function
during normal brain development may contribute to the increased
likelihood of developing psychiatric disorders in adulthood
[10,17,18]. In contrast, the caudate nucleus (CN), a part of the
basal ganglia, has been implicated in motor control, stimulus
response and habit learning [19,20]. The CN receives synaptic
inputs from the dorsolateral PFC [21,22] and may also be involved
in cognitive dysfunction of schizophrenia [23,24]. However, the
CN has received much less attention despite the fact that the CN
had more genes differentially expressed than the PFC in
individuals with schizophrenia [25].
Mitochondria generate energy as adenosine triphosphate (ATP)
and are involved in the apoptosis-signaling pathway [26].
Hundreds of nuclear genes and a few dozen mitochondrial genes
coordinate complex mitochondrial function such as intracellular
ATP and calcium buffering, oxidative phosphorylation, synaptic
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activity and apoptosis. Mitochondrial dysfunction has been
implicated in a variety of pathological conditions including
developmental disorders in primates [27,28,29,30]. Furthermore,
somatic deletions of mitochondrial DNA (mtDNA) may be
associated with development and aging [31,32]. A spectrum of
somatic mutations in mtDNA may be due to oxidative damage
during normal aging. For instance, the breakdown of dopamine by
mitochondrial monoamine oxidase B (MAOB) produces H2O2
which can lead to oxygen radical formation [33]. This may
increase the spectrum of somatic mutations produced by oxidative
damage. Thus, brain regions that are involved in dopamine
metabolism such as the prefrontal cortex (PFC) and the caudate
nucleus (CN) may be particularly vulnerable to oxidative damage.
Previous studies reported developmental patterns of gene expres-
sion in the PFC of human brain tissue [2,34,35]. However,
expression profiles of mitochondrial genes were not described in
those studies. A study reported that approximately 20 genes
associated with the mitochondrial membrane are enriched in
developing human brains based on the template matching
procedure and the gene set enrichment analysis [36]. A
comprehensive expression profile of mitochondrial genes in the
PFC and the CN has not been reported.
Mitochondrial genes are implicated in psychiatric disorders
including schizophrenia [37], bipolar disorder [38], major
depression [39], anxiety disorder [40], and posttraumatic stress
disorder [41]. For example, a significant decrease in mitochondrial
ATP production and mitochondrial enzyme activity was found in
individuals with major depression [42]. Also, genes associated with
mitochondrial function and immune responses were differentially
expressed in the individuals with bipolar disorder and major
depression [43]. Furthermore, genes involved in energy metabo-
lism and mitochondrial function were down-regulated [38,44] and
genes involved in immune response and inflammation were up-
regulated in bipolar disorder patients [45,46]. One of the major
modulators of mitochondrial function is BCL-2 which is embedded
in the inner mitochondrial membrane. Transgenic mice over-
expressing Bcl-2 in the brain showed a decrease in anxiety and
neophobia [47], whereas Bcl-2 knockout mice showed a significant
increase in anxiety-like behavior [40], suggesting the involvement
of Bcl-2 in anxiety disorders. Together, these studies indicate that
the genes associated with mitochondria may play a significant role
in mood and anxiety disorders.
Although mitochondrial dysfunction during development may
contribute to the development of mood and anxiety disorders
[40,48,49,50], molecular mechanisms by which mitochondrial
genes influence brain development and fear-related behavior
remain unclear. Using microarray data available from the public
domain and Gene Ontology analysis, we surveyed genes and
functional categories associated with age in the cortical (PFC) and
the sub-cortical (CN) areas of psychiatrically normal subjects
ranging in age from birth to 50 years. Expression profiles of
different genes from this microarray dataset have been published
[1,2,35,36], and we are testing a novel hypothesis using
mitochondria-associated genes. Using mice selectively bred for
high and low fear, we investigated the effects of age and altered
fear behavior on mitochondrial gene expression. To our knowl-
edge, this is the first study reporting developmental expression
patterns of mitochondrial genes in different brain regions and
altered fear responses. Our study demonstrates the utility of
integrating the expression data derived from postmortem brain
tissue of psychiatrically normal individuals and a mouse model of
fear to enhance our understanding of the mitochondrial function
in brain development and fear-related disorders.
Results
Age-related Genes in the PFC and the CN
Individual variable analyses revealed that brain pH affected
expression of a significant number of transcripts: 6.6% of the
transcripts in the PFC and 0.24% of the transcripts in the CN.
Other demographic variables such as postmortem interval (PMI)
(PFC: 1.9% and CN: 0.08%), RNA Integrity Number (RIN) (PFC:
1.1% and CN: 0.3%), race (PFC: 0.4% and CN: 0.1%) and sex
(PFC: 0.1% and CN: 0.1%) affected a relatively small number of
transcripts. Thus brain pH was adjusted using a multiple
regression model. We identified genes showing linear changes
across age such as 1,236 genes (716 increase and 520 decrease) in
the PFC and 1,745 genes (985 increase and 760 decrease) in the
CN based on the significance criteria (r2.0.6 and qv ,0.05)
(Figure S1). Using those age-related genes, we performed Gene
Ontology (GO) analyses and found the same GO term:
mitochondrion that is enriched in both the PFC (115 genes, fold
change: 1.96, FDR ,5%) and the CN (117 genes, fold change:
1.4, FDR ,5%) as shown in Table 1.
Expression of Mitochondrial Genes in the PFC
A majority of the genes associated with the GO term:
mitochondrion in the PFC (105/115 genes, 91%) showed a linear
increase in expression during postnatal development (Figure 1).
Among those, multiple genes encode different subunits of the same
protein that are involved in the oxidative phosphorylation function
(Table S1). For example, 17 genes encode sub-complexes of the
NADH dehydrogenase (NDUF), 6 genes encode the ATP synthase
(ATP5), 6 genes encode the cytochrome c oxidase (COX) and 3
genes encode the ubiquinol-cytochrome c reductase (UQCR) as
shown on the right side of Figure 1. These suggest that a demand
for energy synthesis and metabolism in the PFC gradually
increases during postnatal development.
Expression of Mitochondrial Genes in the CN
Although an overall number of age-related genes associated
with the GO term: mitochondrion was similar between the PFC
(115) and the CN (117), individual gene expression patterns were
quite different. While a majority of the genes in the PFC (91%)
showed a linear increase with age, less number of the genes in the
CN (62%) showed the same pattern with age (Figure 2). On the
contrary to the age-related genes in the PFC (43), fewer genes (17)
in the CN encode different subunits of the same protein as shown
on the right side of Figure 2.
Quantitative PCR
Using quantitative PCR, we validated the developmental
expression patterns of four genes including monoamine oxidase
B (MAOB), NADH dehydrogenase (ubiquinone) flavoprotein
(NDUFV1), mitochondrial uncoupling protein 5 (SLC25A14) and
tubulin beta-3 chain (TUBB3) in the PFC. We selected these genes
because they are included in the list of 115 genes from the GO
term: mitochondrion and have been implicated in psychiatric
disorders: monoamine oxidase B [51,52], NADH dehydrogenase
(ubiquinone) flavoprotein [53,54], mitochondrial uncoupling
protein 5 [55], and tubulin [56,57]. We have confirmed that the
microarray and the qPCR data were consistent, with all four genes
showing the same directional changes in both experiments. We
used the multiple regression analysis including brain pH as a
covariate, and calculated the adjusted coefficient (r2) and adjusted
p-value for each gene. Expression levels of MAOB (r2 = 0.55,
qv= 7.5E-10), NDUFV1 (r2 = 0.63, qv= 1.8E-08), and SLC25A14
(r2 = 0.53, qv = 3.1E-05) gradually increased while the levels of
Mitochondrial Genes in Development and Fear
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TUBB3 (r2 = 0.51, qv= 4.3E-06) decreased across chronological
age (Figure 3).
Expression of Mitochondrial Genes in Mice with High and
Low Fear
We investigated the effects of age and fear behavior in mice
selectively bred for high and low fear. We quantified the
expression levels of the same genes including MAOB, NDUFV1,
SLC25A14 and TUBB3 in the PFC of juvenile and adult mice
selectively bred for high and low fear (Figure 4). For MAOB, there
was a significant interaction between age and fear (F [1,79] = 8.68,
p,0.05). A post-hoc analysis revealed significant effects between
juvenile and adult mice selectively bred for low fear (Figure 4A).
Expression levels of NDUFV1 were not different between these
groups (p.0.05) as shown in Figure 4B. Expression levels of
SLC25A15 were higher in adult mice as compared to juvenile mice
(p,0.05) as shown in Figure 4C. For TUBB3, a significant
interaction between age and fear was found (F [1,79] = 7.88,
p,0.05). Among the low fear mice, the levels of TUBB3 were
lower in adult mice as compared to juvenile mice (p,0.05)
(Figure 4D). These results indicate that the mice selectively bred
for low fear exhibit normal developmental expression pattern of
those genes. However, the mice selectively bred for high fear
exhibit disrupted expression patterns of MAOB and TUBB3 in the
PFC during postnatal development.
Discussion
A normal mitochondrial function is critical for synaptogenesis
and spine formation [58,59], and for normal apoptosis to occur
[60,61]. Thus, increased expression of the genes associated with
mitochondrial function in the PFC during development may
reflect ongoing maturation and neuronal plasticity, especially
during adolescence [36]. For instance, MAOB is present on the
outer membrane of the mitochondria and function primarily to
maintain the cytosolic concentrations of monoamines. The precise
spatial and temporal pattern of the monoamine neurotransmitter
systems is known to be important in orchestrating the development
of the neural circuitry of the brain [62,63,64]. Consequently, the
metabolism of the monoamines by MAOB in the developing brain
is going to be fundamental for brain development and function.
Given that MAOB expression levels gradually increase in the PFC
during normal brain development, a lack of developmental
changes in MAOB levels observed in high fear mice indicates a
dysfunction of MAOB in these animals. This is an important
finding because MAOB has been implicated in mood and anxiety
disorders including social phobia, panic disorder and post-
traumatic stress disorder (PTSD) [65]. Thus, enhancing MAOB
activity in the PFC may have beneficial effects on fear-related
behavior. Our findings support the notion that monoamines are
involved in mood and anxiety disorders.
We found that the genes associated with the GO term:
mitochondrion undergo age-related changes in expression in both
the PFC and the CN of developing humans. However, only the
genes from the PFC showed a consistent increase in expression
across age. Also there were more genes in the PFC than in the CN
that are involved in oxidative phosphorylation function. A growing
body of evidence suggests mitochondrial dysfunction in affective
disorders involving multiple brain regions, including the PFC [44],
the temporal cortex [66], and the hippocampus [38]. Moreover,
base pair substitutions in the coding regions of mtDNA [67],
altered mitochondrial oxidative phosphorylation [68] and abnor-
mal expression of nuclear genes encoding mitochondrial proteins
[38] have been reported in mood and anxiety disorders. These
results strongly implicate mitochondrial dysfunction in the
pathophysiology of affective disorders [50]. In line with these
findings, the major categories of drugs used to treat depression
have been demonstrated to exert effects on mitochondria as well as
on monoamines [69,70,71]. Also, commonly used mitochondrial-
targeted treatments exert effects on mitochondria and are
increasingly being shown to demonstrate efficacy in mood
disorders [72]. These studies suggest an interaction between the
monoamine system and the mitochondrial system in mood and
anxiety disorders.
Although the mitochondrial system has been implicated in
psychiatric disorders, very little is known about the role of
mitochondrial genes on fear learning in rodents. We investigated
the expression levels of four mitochondrial genes in the PFC of mice
selectively bred for high and low fear. The classical fear conditioning
model has been used extensively to study fear in animals [73] and in
humans [74]. We have found that three mitochondrial genes
(MAOB, SLC25A14 and TUBB3) in the PFC follow age-dependent
changes in expression in mice selectively bred for low fear.
However, normal developmental changes of MAOB and TUBB3
Table 1. Enriched biological pathways in the genes showing age-dependent changes in the PFC and the CN of normal individuals.
Brain Region Category GO Term Count
Fold
Change FDR p-value
PFC GOTERM_CC_ALL GO:0005739,mitochondrion 115 1.96 3.98E-10
PFC GOTERM_CC_ALL GO:0031966,mitochondrial membrane 58 2.62 3.99E-09
PFC GOTERM_BP_ALL GO:0006119,oxidative phosphorylation 28 4.32 8.18E-07
PFC GOTERM_CC_ALL GO:0005746,mitochondrial respiratory chain 22 4.87 9.87E-08
PFC GOTERM_BP_ALL GO:0007399,nervous system development 86 1.96 4.66E-06
CN GOTERM_BP_ALL GO:0007242,intracellular signaling cascade 176 1.42 0.002793
CN GOTERM_BP_ALL GO:0000074,regulation of progression through cell cycle 75 1.72 0.003894
CN GOTERM_BP_ALL GO:0007399,nervous system development 101 1.56 0.005043
CN GOTERM_CC_ALL GO:0005739,mitochondrion 117 1.4 0.009768
CN GOTERM_BP_ALL GO:0008219,cell death 103 1.49 0.012914
Functional annotation analyses (Gene Ontology) were performed using 2 sets of genes (genes changing expression in the PFC and genes changing expression in the
CN). Count: number of genes included in each category, Fold: fold enrichment, FDR: false discovery rate-adjusted p-values based on the Benjamini-Hochberg method
[84].
doi:10.1371/journal.pone.0049183.t001
Mitochondrial Genes in Development and Fear
PLOS ONE | www.plosone.org 3 November 2012 | Volume 7 | Issue 11 | e49183
were disrupted in mice selectively bred for high fear. This is
significant because mice selectively bred for high fear resemble
individuals who are more susceptible to develop fear-related
disorders [75]. Thus, disrupted expression levels of MAOB and
TUBB3 in the PFC of mice with high fear may contribute to
exaggerated fear responses observed in these animals.
A limitation of this study is that we had a relatively smaller number
of postmortem brain samples from the CN (n=14) as compared to
the PFC (n=48), so the statistical power may be compromised.
However, we observed a similar number of genes associated with
mitochondrial function in the PFC (115 genes) and the CN (117
genes) using the same criteria of significance (r2.0.6 and FDR q-
value ,0.05). It is possible that other factors such as nutrition,
metabolism or common deletions in mtDNA associated with aging
may have affected expression of certain mitochondrial genes. It
would be important to corroborate the current gene expression
findings from developing brains with other types of data such as brain
imaging, neuropsychological and cognitive testing to enhance our
understanding on human brain development and function. Another
limitation is that a limited number of mitochondrial genes were tested
in the PFC of mice with high and low fear. Thus it is possible that
other mitochondrial genes that were not investigated in this study
may also contribute to fear and anxiety behavior. Also, we did not
study effects of stress on fear behavior in these animals and a further
study is necessary to expand the current findings.
In summary, we identified a substantial number of genes
associated with mitochondria that undergo age-dependent changes
in the PFC and the CN of psychiatrically normal individuals. A
majority of the genes in the PFC (105/115) showed a linear
increase in expression across age and 27% of them (28/105) were
related to oxidative phosphorylation function. Using mice
selectively bred for high and low fear, we found that age-
Figure 1. Developmental expression pattern of the genes associated with mitochondrial function in the PFC. A majority of the
mitochondrial genes (91%) show increased expression (green to red), while only 9% of the genes show decreased expression (red to green) during
postnatal development. Genes that encode different subunits of the same protein are shown on the right side. X-axis: Age (years). Y-axis: Gene
symbols. In this pseudo-color heat map, increasing red intensities indicate genes with high expression levels, and increasing green intensities indicate
genes with low expression levels across age. Color bar scale: hybridization intensity (log base 2) from 2.41 to 11.72.
doi:10.1371/journal.pone.0049183.g001
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dependent changes in expression ofMAOB and TUBB3 in the PFC
were disrupted in animals with high fear. Since mitochondrial
dysfunction can lead to multiple abnormalities in cell function
[76,77], disruptions in normal developmental changes of the genes
during the sensitive period may predispose the individuals to the
development of mood and anxiety disorders. Taken together, a
better understanding of the genes associated with the mitochon-
drial function in the PFC may provide an opportunity to identify a
novel drug target for the treatment of mood and anxiety disorders.
Materials and Methods
Postmortem Brain Tissue and Microarray Experiment
Postmortem brain tissue from the PFC (Brodmann Area 46) and
dorsal head of the CN ranging in age from birth to 50 years were
obtained from the National Institute of Child Health and
Development Brain and Tissue Bank for Developmental Disorders
(NICHD Contract NO1-HD8-3283; IRB approval H-20765)
(Table S2). Details on sample collection and consent information
is available from a previous report [78]. Brain tissue from the CN
was not available from all the subjects, and this resulted in much
fewer samples included in the microarray experiments (PFC: 48
samples and CN: 14 samples) (Figure S2). The brain collection
protocol was reviewed and approved by the Institutional Review
Board of the University of Maryland, Baltimore. All subjects were
free of neurological and psychiatric symptoms at the time of death
as described previously [79]. A microarray experiment (Affymetrix
HG-U133 plus 2.0 GeneChip) was performed by Dr. Paabo’s
Figure 2. Developmental expression pattern of the genes associated with mitochondrial function in the CN. Approximately 62% of the
genes (72/117) show increasing expression (green to red), while 38% of the genes (45/117) show decreasing expression (red to green) during
development. X-axis: Age (years). Y-axis: Gene symbols. Genes that encode different subunits of the same protein are shown on the right side. On the
contrary to the PFC, very few genes encode different subunits of the same protein. Color bar scale: hybridization intensity (log base 2) from 4.45 to
13.56.
doi:10.1371/journal.pone.0049183.g002
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group (Max Planck Institute, Germany) and findings from this
dataset were published previously [2,35,36].
Quality Control of Microarrays
Raw data (.cel files) were processed and analyzed using the R
statistical language (http://www.r-project.org) and Bioconductor
packages [80]. A robust multi-array average (RMA) algorithm was
used for normalization of expression values (log base 2) for each
transcript [81]. Microarray data quality was assessed using a pair-
wise sample correlation coefficient with hierarchical clustering to
identify sample outliers. Transcripts were filtered out if 20% or
more of the subjects had expression values of less than a 1.1-fold
change in either direction from the transcript’s median value and if
the percent of subjects with an absent gene call exceeded 33% using
the Affymetrix calls. We used this procedure to remove transcripts
that are not expressed or changed across the samples before the
statistical analysis [82]. After the gene filtering, 21,391 transcripts
for the PFC and 22,356 transcripts for the CN were retained.
Microarray Data Analysis
First, individual demographic factors were analyzed to identify
potential confounding factors affecting the expression of a
significant number of genes. The number of transcripts signif-
icantly regulated by each variable including brain pH, postmortem
Figure 3. Quantitative PCR validation of mitochondrial genes. A scatter plot with a line of best fit demonstrates that each gene in the PFC
shows either increase or decrease in expression across age (qv ,0.05). X-axis: Age (log 2 scale). Y-axis: Gene expression (log 2 scale). Subjects were
color-coded as red: neonate (0–3 months), green: infant (3–12 months), blue: toddler (1–5 years), light blue: school age (6–13 years), pink: teenage
(14–19 years), yellow: young adult (20–30 years), and grey: adult (31–50 years). A: MAOB (monoamine oxidase B), B: NDUFV1 [NADH dehydrogenase
(ubiquinone) flavoprotein 1, 51 kDa], C: SLC25A14 (mitochondrial uncoupling protein 5), D: TUBB3 (tubulin beta-3 chain).
doi:10.1371/journal.pone.0049183.g003
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interval (PMI), RNA integrity number (RIN), race and sex was
calculated using a linear regression model (p,0.001). Following
the demographic factor analysis, linear gene expression changes
across chronological age were analyzed in a series of multiple
regression models, one model for each gene, including age (log
base 2) and brain pH (as a confounder) as independent variables
and gene expression (log base 2) as a dependent variable. To adjust
for multiple testing of the genes, the calculated p-values
corresponding to the age covariate for each gene were adjusted
to give an overall false discovery rate (FDR) of 5% using the q-
value package (www.bioconductor.org). The criteria of significance
were set at adjusted coefficient r2.0.6 and FDR q-value ,0.05.
The microarray data are available from the Gene Expression
Omnibus (GEO) under the accession number GSE11512.
Gene Ontology Analysis
The NCBI’s Database for Annotation, Visualization and
Integrated Discovery (DAVID; http://david.abcc.ncifcrf.gov/)
was used as a standard source for gene annotation information
[83]. A modified Fisher’s Exact test (EASE) was used to measure
the gene set enrichment in the annotation terms. A set of genes
associated with age in each brain region was used in an annotation
term-by-annotation term contingency test to identify the associ-
ation between each gene set and annotation term. Both nominal
and FDR adjusted p-values for each test were calculated, and the
significance threshold for the GO term was set at FDR-adjusted
p,0.05 [84].
Mice Selectively Bred for High and Low Fear
Mice were derived from the F8 generation of C57BL/6J (B6) X
DBA/2J (D2) advanced intercross line (AIL). The foundation AILs
were created and tested by Dr. Abraham Palmer and colleagues
(University of Chicago, Chicago IL) [85,86,87]. The F8 AILs were
trained and tested for cued and contextual fear [88], and mice that
display either enhanced (top 20%) or diminished (bottom 20%)
conditioned fear (selected generation 1) were shipped to the
Figure 4. Expression levels of mitochondrial genes in the PFC of juvenile and adult mice selectively bred for high and low fear. The
expression levels of mitochondrial genes in the PFC of mice selectively bred for high and low fear were measured in either 1 month (clean bar) or 4
months (hatched bar) of age. A: MAOB (monoamine oxidase B), B: NDUFV1 [NADH dehydrogenase (ubiquinone) flavoprotein 1, 51 kDa], C: SLC25A14
(mitochondrial uncoupling protein 5), D: TUBB3 (tubulin beta-3 chain). Data shown as an average and SEM. *Significant between juvenile and adult
mice (p,0.05).
doi:10.1371/journal.pone.0049183.g004
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Uniformed Services University of the Health Sciences where
breeding and selection continued. Thus, these animals represent
alternative condition as compared to the animals in the middle
that were not selected for breeding. Juvenile (approximately 1
month) and adult (approximately 4 months) mice from the third
and the fourth generations that display high and low fear were
used in this experiment including juvenile mice with high fear
(N= 31) and low fear (N= 19), and adult mice with high fear
(N= 21) and low fear (N= 12). Animals were screened for high and
low fear using Pavlovian fear conditioning. Mice were placed in
Plexiglas rodent conditioning chambers with a metal grid floor
(Ugo Basile, Collegeville, PA) and a single house light provided
dim lighting within sound attenuation boxes. Mice were given a
3 min baseline to adjust to the context and then presented with
two 30 sec tones (conditioned stimuli [CS], 5 kHz, 75 dB) that
terminated with a mild electric foot shock (unconditioned stimuli
[US], 0.5 sec, 0.8 mA) using the AnyMaze program (Stoelting Co.,
Wood Dale, IL). The following day, animals were placed in the
identical chamber with no tones or shocks presented and freezing
in response to the test chamber (contextual fear) was measured for
5 min. For cue-specific fear, the context of the chamber was
changed, which included covering the house light with yellow
acetate film. Striped and checkered patterns were placed around
the Plexiglas and a white plate was placed over the metal grid
floor. With the change in context, the mice were tested on freezing
in response to the tone (CS). The mice were monitored with
infrared cameras, which measured freezing time for each animal
during the testing (ANY-maze program, Stoelting Co., Wood
Dale, IL). These animals showed clear differences in conditioned
fear behavior as reported previously [89]. For example high fear
and low fear mice exhibited approximately 55% and 30% freezing
behavior respectively during CS presentation. An animal protocol
was approved by the IACUC at the Uniformed Serviced
University, Bethesda, MD.
RNA Extraction from Mouse Brain Tissue
Coronal sections of 1.5 mm mouse brain slices were acquired
using an acrylic brain block (Braintree Scientific, Braintree, MA)
and surgical razor blades on wet-ice (4uC). The medial PFC was
punched out using a 14-gauge needle, and immediately frozen in
dry ice. Brain tissue was homogenized by ultrasonication and total
RNA was extracted using the RNeasy Minikit (Qiagen, Valencia,
CA, USA). Complementary DNA was synthesized using a reverse-
transcriptase polymerase chain reaction (RT-PCR) using oligo dT
primers.
Quantitative PCR
Total RNA was extracted from the PFC of the same subjects as
described in postmortem brain tissue section above, and the cDNA
was synthesized with RT-PCR using oligo dT primers. Pre-
designed and validated QuantiTect SYBR primers (Qiagen,
Valencia, CA, USA) were used for the qPCR: MAOB
(QT00009870, NM_000898), NDUFV1 (QT00003080,
NM_007103), SLC25A14 (QT00040544, NM_003951), and
TUBB3 (QT00083713, NM_006086). Three endogenous control
genes including PP1A (QT01866137, NM_021130), GUSB
(QT00046046, NM_000181) and ACTB (QT00095431,
NM_001101) were used. For mouse brain tissue, oligonucleotide
primers were designed using the Primer 3 software (http://frodo.
wi.mit.edu/primer3/). Primer sequences were Maob (forward:
cagccagaaccagaatctttg, reverse: gctgacaagatggtggtcaat), Ndufv1
(forward: cgttgactggatgaacaaggt, reverse: gtgtggccttctatctgcttg),
Slc25a14 (forward: tgaatcagagggcaatagtgg, reverse: atgatgttc-
cagggtccaagt) and Tubb3 (forward: gaatgacctggtgtccgagta, reverse:
cgattcctcgtcatcatcttc). Using a 384-well format with the Prism
7900HT real-time detector (Applied Biosystems, Foster City, CA),
1 ml aliquots of Qiagen QuantiTect SYBR primer, 10 ml qPCR
PCR Master mix (Applied Biosystems, Foster City, CA), and 10 ml
cDNA were mixed together and pipetted into single wells of the
qPCR plate. Reactions were quantified by the cycle threshold (Ct)
method using the SDS2.2 software (Applied Biosystems, Foster
City, CA). An average quantity value (Qty mean) for each sample
from the triplicates of that sample was calculated for each gene.
The data for each gene were expressed as Qty mean for the gene
of interest/geometric mean of Qty mean for the three endogenous
control genes. Multiple regression analyses were performed with
chronological age (log base 2) and brain pH as covariates as
described previously [79]. For the mice data, a two way ANOVA
(age X fear) for interaction and main effects followed by post-hoc
tests were performed using normalized values of the individual
genes.
Supporting Information
Figure S1 Distribution of actual age across samples
(PFC: n=46 and CN: n=13). There were more samples with
age below 10 (25 out of 46 samples) in the PFC as described in the
demographic summary table. In order to better describe the
expression changes during early development, we used a log2 scale
of age in Figure 3.
(DOCX)
Figure S2 A Venn diagram showing the total number of
genes with age-related expression changes between the
PFC and the CN (r2.0.6 and FDR qv ,0.05). There were
1,236 genes (716 increased and 520 decreased) in the PFC and
1,745 genes (985 increased and 760 decreased) in the CN that
undergo age-related changes in expression.
(DOCX)
Table S1 A summary of demographic information. PMI:
Postmortem interval, RIN: RNA integrity number M: Male, F:
Female, AA: African American, C: Caucasian
(DOCX)
Table S2 Information on the genes associated with the
GO term: mitochondrion in the PFC and the CN. r2:
adjusted coefficient, r: regression coefficient, q value: FDR-
adjusted q-value
(DOCX)
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